Genesis Pharmaceuticals Limited
03850289
Healthy
- Going concern doubt noted in accounts (-10)
- 3 outstanding charges (-6)
Details
Compliance
Last accounts
31/12/2024
medium
Next accounts due
30/09/2026
Confirmation statement
Last: 05/03/2026
Due 19/03/2027
Industry
Officers
secretary · Since 29/09/1999
DIRECTOR
BRITISH · UNITED KINGDOM · Age 63
Also on 7 other boards
director · Since 29/09/1999
DIRECTOR
BRITISH · UNITED KINGDOM · Age 55
Also on 11 other boards
director · Since 01/10/2010
COMMERCIAL DIRECTOR
BRITISH · ENGLAND · Age 69
Persons with Significant Control
Mr David Louis Charles Solomon
British · United Kingdom · Age 55
Scottish Provident House, 3rd Floor, Harrow, HA1 1BQ
Notified 30/12/2022
Former PSCs
Genethics Europe Limited
Ceased 30/12/2022
Charges3 outstanding
BARCLAYS BANK PLC
BARCLAYS BANK PLC
A & P BOLDING LIMITED
BARCLAYS BANK PLC
NMB-HELLER LIMITED
THE ROYAL BANK OF SCOTLAND INTERNATIONAL LIMITED
CompanyRankvs 210+ SIC 46460 peers60
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 31/12/2024
Turnover
£45.1M
Annual revenue
Net Worth
£2.7M
Balance sheet strength
Cash
£195k
Cash in the bank
Profit Before Tax
£324k
Bottom line earnings
Net Current Assets
£1.3M
Working capital
Current Assets
£12.4M
Current Liabilities
£11.1M
Fixed Assets
£1.4M
Debtors
£12.2M
Cost of Sales
£42.8M
Gross Profit
£2.4M
Admin Expenses
£2.1M
Operating Profit
£327k
Profit After Tax
£250k
Tax at Year End
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 1.12 | +£250k |
| 2023 | 1.08 | +£252k |
| 2022 | 1.04 | — |
Derived from filed accounts. Not audited figures.